Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - constantinos+koumenis
Radiation sensitizers to enhance treatment of malignant tumors
Radio-sensitizing compounds for glioblastoma and other solid cancer Problem: Glioblastoma Multiforme (GBM), the most common primary brain tumor in adults, is an aggressive and locally invasive tumor. Despite advances in surgery, radiotherapy, and chemotherapy, overall survival of patients affected by GBM has only marginally increased from 6 to 14 months...
Therapeutics & Vaccines
© 2021. All Rights Reserved. Powered by